Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Obtains Distribution Rights to Qiagen's PCR Kits for HLA Typing

NEW YORK (GenomeWeb News) – Dutch molecular diagnostics company GenDx announced today that Qiagen has granted it non-exclusive rights for the worldwide distribution for Qiagen's LongRange PCR kit in combination with GenDx's SBTexcellerator reagents for high-resolution HLA typing.

The agreement covers both direct distribution by GenDx as well as third-party distribution.

The combination of the LongRange PCR kit and SBTexcellerator reagents allows researchers to amplify HLA genes beyond the exon 2, 3, and 4 regions, making it possible to identify by sequencing other important regions of HLA genes, GenDx said.

"This distribution agreement enables GenDx and [its] partners to even better fulfill the requirements of our customers worldwide to efficiently obtain reliable HLA-typing results," Wietse Mulder, managing director for GenDx, said in a statement.

SBTexcellerator reagents received CE Marking in September for high-resolution HLA typing. GenDx and Qiagen have an ongoing collaboration to develop and commercialize products for HLA testing, and Qiagen is the exclusive worldwide distributor for the SBT reagent line.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.